marcus evans europe conferences

Global Anti-Corruption and Corporate Compliance for Pharma

Delivering Effective Third Party Management and Best Practice Compliance

12-13 September 2013
Novotel am Tiergarten, Berlin, Germany

Conference Workshop

Managing Third Party Risks and Formulating Effective Due Diligence Delivery

Workshop Moderator: Daniel Kessler

Company: Principal Givon Advisors Ltd ITR Compliance Group

Why You Should Attend

Global Anti-Corruption and Corporate Compliance for Pharma

As the pharma industry becomes more saturated and competitive, reports on corruption have increased dramatically over the last few years, due to the international trade, complex relationships with third parties and expansion into emerging markets. Following the recent legislations updates including FCPA, UK Bribery Act, Sunshine Act and the new International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) code, many pharma and medical device companies have been scrutinised for allegedly violating corruption laws and charged with severe criminal and civil actions. Those who have a working compliance programme cannot be complacent as regulations continuously change. Pharmaceuticals must be able to stay on top of their internal procedures as well as monitor their third parties to prevent risk of losing millions in revenue and damaging their reputation.


This conference will bring together leading pharmaceuticals and medical device companies to discuss the challenges and best practices to manage risks and enhance your compliance programme. Attendees will benefit from practical solutions provided by industry leading peers with the best possible advice on how to implement a global compliance programme that works best for you and your third parties.



Key Topics

  • Learn practical lessons from peers in the recent enforcement action of the FCPA, Sunshine Act and UKBA
  • Benchmark your anti-corruption and compliance programme against your peers’
  • Explore different approaches to effectively manage your 3rd parties and HCP payments in developing markets
  • Mitigate compliance risks and bullet-proofing your due diligence programme
  • Leverage solutions from leading companies to build and maintain a global compliance programme
  • Previous Attendees Include

    Directors, VPs, Heads, Managers, Coordinators of:
    •Anti-Corruption & Bribery
    •Compliance & Ethics
    •General Counsel
    •Internal Audit
    •Regulatory Affairs
    •Monitoring & Assurance
    •Fraud Investigations & Due Diligence
    •HCP Payment
    •Pharmas & Biotechs
    •Medical Device Companies
    •Distributors & Wholesalers
    •Consumer Healthcare
    •Solution Providers

    Previous Attendees Included:
    •Boehringer Ingelheim GmbH
    •Bristol-Myers Squibb
    •F. Hoffmann La-Roche
    •Merck Serono
    •Novartis Pharma AG
    •Takeda Cambridge Ltd.
    Testimonials from Past Attendees:
    •‘Excellent networking opportunities and quality presentations!’– Pfizer
    •‘Very organised and informative event!’– Novartis
    •‘Very structured forum with excellent discussions!’– GSK
    •‘Top notch speakers who gave good insight into the subject!’– Sanofi

    marcus evansPremier Events Included:
    •12thAnnual Project & Portfolio Management for Pharma
    •Strategic Intellectual Property & Patent Management for Pharma
    •4thAnnual Anti-Corruption & Compliance for the Oil, Gas and Extractive Industries

    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.

    Event Sponsors
    Axis Risk Consulting Services Pvt Ltd
    Visit website >>

    Event Partners

    Practical Insights From

    Giuseppe Palmieri
    Head of Risk & Compliance Management and Audit, Chief Compliance Officer & Vice President
    Boehringer Ingelheim Italia S.p.A.& Osservatorio 231 Farmaceutiche

    Maurizio Arena
    Osservatorio 231 Farmaceutiche

    Perry Goldman
    Vice President & Deputy General Counsel
    Onyx Pharmaceuticals

    Karl Boonen
    Senior Director Business Practices & Compliance EMEA & Canada
    Johnson & Johnson

    Tomasz Kruk
    Director Global Ethics & Compliance

    Richard Bergström
    Director General
    European Federation of Pharmaceutical Industries and Associations

    Andreas Gascard
    Senior Director EMEA & Canada Center of Excellence
    Johnson & Johnson

    Sébastien Bergier
    Compliance Liaison Director
    F. Hoffmann-La Roche Ltd.

    Click Here For Full Agenda

    Voice of Our Customers
    Join the Discussion

    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Kristiyan Sokolov

    PO Box 24797
    CY-1304 Nicosia

    +357 22 849 408
    Fax: +357 22849 394